TD Cowen Maintains Buy on Elevance Health, Raises Price Target to $465

Benzinga Newsdesk www.benzinga.com Positive 73.7%

Neg 0% Neu 0% Pos 73.7%

TD Cowen analyst Ryan Langston maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $400 to $465.